Collectively, these findings suggest that erythritol may promote arterial thrombosis and cerebrovascular dysfunction by enhancing platelet adhesion and activation, accelerating atherosclerosis, increasing oxidative stress, reducing nitric oxide bioavailability, and elevating ET-1 production, thereby contributing to the increased risk of CHD and IS. Here, EDN1 is linked to deep vein thrombosis.